Galectin Therapeutics Files 2024 10-K
Ticker: GALT · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1133416
| Field | Detail |
|---|---|
| Company | Galectin Therapeutics INC (GALT) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
GALECTIN THERAPEUTICS INC filed its 2024 10-K. Full financial picture inside.
AI Summary
Galectin Therapeutics Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Pro Pharmaceuticals Inc., is focused on pharmaceutical preparations and is incorporated in Nevada. Key financial details and operational highlights for the fiscal year are detailed within the report.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Galectin Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Galectin Therapeutics likely faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-31 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- GALECTIN THERAPEUTICS INC (company) — Filer
- PRO PHARMACEUTICALS INC (company) — Former company name
- 2024-12-31 (date) — Fiscal year end
- 20250331 (date) — Filing date
- NV (state) — State of incorporation
- GA (state) — Business and mail address state
- 678-620-3186 (phone_number) — Business phone
FAQ
What is the primary business of Galectin Therapeutics Inc.?
Galectin Therapeutics Inc. is primarily involved in pharmaceutical preparations, as indicated by its SIC code [2834].
When did Galectin Therapeutics Inc. change its name?
The company changed its name from PRO PHARMACEUTICALS INC on 20010612.
In which state is Galectin Therapeutics Inc. incorporated?
Galectin Therapeutics Inc. is incorporated in Nevada (NV).
What is the business address of Galectin Therapeutics Inc.?
The business address is 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA 30071.
What is the fiscal year end for the reported 10-K?
The fiscal year end for this 10-K filing is December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding GALECTIN THERAPEUTICS INC (GALT).